Pfizer Inc. (NYSE:PFE) has a beta value of 0.69 and has seen 5,352,722 shares traded in the recent trading session. The company, currently valued at $212.72 Billion, closed the recent trade at $38.16 per share which meant it gained $0.37 on the day or 0.98% during that session. The PFE stock price is -7.36% off its 52-week high price of $40.97 and 26.94% above the 52-week low of $27.88. If we look at the company’s 10-day average daily trading volume, we find that it stood at 23.09 Million shares traded. The 3-month trading volume is 31.29 Million shares.
The consensus among analysts is that Pfizer Inc. (PFE) is an Overweight stock at the moment, with a recommendation rating of 2.5. None of the analysts rate the stock as a Sell, while 2 rate it as Overweight. 8 out of 15 have rated it as a Hold, with 5 advising it as a Buy. None have rated the stock as Underweight. The expected earnings per share for the stock is $0.71.
Pfizer Inc. (NYSE:PFE) trade information
Sporting 0.98% in the green today, the stock has traded in the green over the last five days, with the highest price hit on Thursday, Aug 06 when the PFE stock price touched $39.10- or saw a rise of 3.12%. Year-to-date, Pfizer Inc. shares have moved -3.32%, while the 5-day performance has seen it change -1.48%. Over the past 30 days, the shares of Pfizer Inc. (NYSE:PFE) have changed 11.97%. Short interest in the company has seen 53.49 Million shares shorted with days to cover at 1.71.
Wall Street analysts have a consensus price target for the stock at $41.69, which means that the shares’ value could jump 9.25% from current levels. The projected low price target is $35 while the price target rests at a high of $53. In that case, then, we find that the current price level is +38.89% off the targeted high while a plunge would see the stock lose -8.28% from current levels.
Pfizer Inc. (PFE) estimates and forecasts
Figures show that Pfizer Inc. shares have underperformed across the wider relevant industry. The company’s shares have lost -0.79% over the past 6 months, with this year growth rate of -1.69%, compared to 8.3% for the industry. Other than that, the company has, however, lowered its growth outlook for the 2020 fiscal year revenue. Growth estimates for the current quarter are -5.3% and 14.5% for the next quarter. Revenue growth from the last financial year stood is estimated to be -4.3%.
6 analysts offering their estimates for the company have set an average revenue estimate of $12.29 Billion for the current quarter. 5 have an estimated revenue figure of $13.21 Billion for the next quarter concluding in December 01, 2020. Year-ago sales stood $12.68 Billion and $12.69 Billion respectively for this quarter and the next, and analysts expect sales will grow by -3.1% for the current quarter and 4.1% for the next.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was +14.7% over the past 5 years. Earnings growth for 2020 is a modest +62.3% while over the next 5 years, the company’s earnings are expected to increase by 5.37%.
Pfizer Inc. is expected to release its next earnings report between October 27 and November 02 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue. The forward dividend is 1.52 at a share yield of 4.02%. The company’s dividend yield has gone up over the past 12 months, with a 5 Year Average Dividend Yield of 3.58%.
Pfizer Inc. (NYSE:PFE)’s Major holders
Insiders own 0.04% of the company shares, while shares held by institutions stand at 72.56% with a share float percentage of 72.59%. Investors are also buoyed by the number of investors in a company, with Pfizer Inc. having a total of 3140 institutions that hold shares in the company. The top two institutional holders are Vanguard Group, Inc. (The) with over 461.98 Million shares worth more than $15.08 Billion. As of March 30, 2020, Vanguard Group, Inc. (The) held 8.31% of shares outstanding.
The other major institutional holder is Blackrock Inc., with the holding of over 424.07 Million shares as of March 30, 2020. The firm’s total holdings are worth over $13.84 Billion and represent 7.63% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are Vanguard Total Stock Market Index Fund and Vanguard 500 Index Fund. As of March 30, 2020, the former fund manager holds about 2.92% shares in the company for having 162000000 shares of worth $5.3 Billion while later fund manager owns 113.93 Million shares of worth $3.72 Billion as of March 30, 2020, which makes it owner of about 2.05% of company’s outstanding stock.